326 related articles for article (PubMed ID: 24502450)
1. Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.
Courter JR; Madani N; Sodroski J; Schön A; Freire E; Kwong PD; Hendrickson WA; Chaiken IM; LaLonde JM; Smith AB
Acc Chem Res; 2014 Apr; 47(4):1228-37. PubMed ID: 24502450
[TBL] [Abstract][Full Text] [Related]
2. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.
Anang S; Richard J; Bourassa C; Goyette G; Chiu TJ; Chen HC; Smith AB; Madani N; Finzi A; Sodroski J
J Virol; 2022 Sep; 96(17):e0063622. PubMed ID: 35980207
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitors.
LaLonde JM; Kwon YD; Jones DM; Sun AW; Courter JR; Soeta T; Kobayashi T; Princiotto AM; Wu X; Schön A; Freire E; Kwong PD; Mascola JR; Sodroski J; Madani N; Smith AB
J Med Chem; 2012 May; 55(9):4382-96. PubMed ID: 22497421
[TBL] [Abstract][Full Text] [Related]
5. HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors.
Zaitseva M; Peden K; Golding H
Biochim Biophys Acta; 2003 Jul; 1614(1):51-61. PubMed ID: 12873765
[TBL] [Abstract][Full Text] [Related]
6. Binding mode characterization of NBD series CD4-mimetic HIV-1 entry inhibitors by X-ray structure and resistance study.
Curreli F; Kwon YD; Zhang H; Yang Y; Scacalossi D; Kwong PD; Debnath AK
Antimicrob Agents Chemother; 2014 Sep; 58(9):5478-91. PubMed ID: 25001301
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state.
Haim H; Si Z; Madani N; Wang L; Courter JR; Princiotto A; Kassa A; DeGrace M; McGee-Estrada K; Mefford M; Gabuzda D; Smith AB; Sodroski J
PLoS Pathog; 2009 Apr; 5(4):e1000360. PubMed ID: 19343205
[TBL] [Abstract][Full Text] [Related]
8. Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.
Dogo-Isonagie C; Lam S; Gustchina E; Acharya P; Yang Y; Shahzad-ul-Hussan S; Clore GM; Kwong PD; Bewley CA
J Biol Chem; 2012 Apr; 287(18):15076-86. PubMed ID: 22403408
[TBL] [Abstract][Full Text] [Related]
9. Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.
Pacheco B; Alsahafi N; Debbeche O; Prévost J; Ding S; Chapleau JP; Herschhorn A; Madani N; Princiotto A; Melillo B; Gu C; Zeng X; Mao Y; Smith AB; Sodroski J; Finzi A
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003492
[TBL] [Abstract][Full Text] [Related]
10. The Discovery and Development of Oxalamide and Pyrrole Small Molecule Inhibitors of gp120 and HIV Entry - A Review.
Motati DR; Uredi D; Watkins EB
Curr Top Med Chem; 2019; 19(18):1650-1675. PubMed ID: 31424369
[TBL] [Abstract][Full Text] [Related]
11. Naturally occurring variability in the envelope glycoprotein of HIV-1 and development of cell entry inhibitors.
Brower ET; Schön A; Freire E
Biochemistry; 2010 Mar; 49(11):2359-67. PubMed ID: 20166763
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
Keller PW; Morrison O; Vassell R; Weiss CD
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors.
Curreli F; Ahmed S; Benedict Victor SM; Iusupov IR; Spiridonov EA; Belov DS; Altieri A; Kurkin AV; Debnath AK
Bioorg Med Chem; 2021 Feb; 32():116000. PubMed ID: 33461144
[TBL] [Abstract][Full Text] [Related]
14. V3 tip determinants of susceptibility to inhibition by CD4-mimetic compounds in natural clade A human immunodeficiency virus (HIV-1) envelope glycoproteins.
Anang S; Zhang S; Fritschi C; Chiu T-J; Yang D; Smith Iii AB; Madani N; Sodroski J
J Virol; 2023 Nov; 97(11):e0117123. PubMed ID: 37888980
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120.
Schön A; Madani N; Klein JC; Hubicki A; Ng D; Yang X; Smith AB; Sodroski J; Freire E
Biochemistry; 2006 Sep; 45(36):10973-80. PubMed ID: 16953583
[TBL] [Abstract][Full Text] [Related]
16. Recent Progress in the Development of HIV-1 Entry Inhibitors: From Small Molecules to Potent Anti-HIV Agents.
Suttisintong K; Kaewchangwat N; Thanayupong E; Nerungsi C; Srikun O; Pungpo P
Curr Top Med Chem; 2019; 19(18):1599-1620. PubMed ID: 31424370
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of coreceptor recognition by HIV-1 envelope spike.
Shaik MM; Peng H; Lu J; Rits-Volloch S; Xu C; Liao M; Chen B
Nature; 2019 Jan; 565(7739):318-323. PubMed ID: 30542158
[TBL] [Abstract][Full Text] [Related]
18. The active core in a triazole peptide dual-site antagonist of HIV-1 gp120.
Umashankara M; McFadden K; Zentner I; Schön A; Rajagopal S; Tuzer F; Kuriakose SA; Contarino M; Lalonde J; Freire E; Chaiken I
ChemMedChem; 2010 Nov; 5(11):1871-9. PubMed ID: 20677318
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.
Curreli F; Haque K; Xie L; Qiu Q; Xu J; Yong W; Tong X; Debnath AK
Bioorg Med Chem; 2015 Dec; 23(24):7618-28. PubMed ID: 26602829
[TBL] [Abstract][Full Text] [Related]
20. Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.
Lu L; Yu F; Cai L; Debnath AK; Jiang S
Curr Top Med Chem; 2016; 16(10):1074-90. PubMed ID: 26324044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
